Global Cardiovascular Safety of Romosozumab in Patients With Rheumatoid Arthritis and Osteoporosis: A Propensity-Matched TriNetX Cohort Study (ACR Convergence 2026) - Sep 8, 2026 - Abstract #2401; Pres time: Nov 10, 2026; 10:30 AM - 12:30 PM; Location: WB1&2; In Person; No abstract available
Clinical • Cardiovascular • Immunology • Inflammatory Arthritis • Osteoporosis • Rheumatoid Arthritis • Rheumatology
|